Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
26.46
-0.48 (-1.78%)
Jul 11, 2025, 9:57 AM - Market open

Palvella Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22
293135--
Enterprise Value
235215--
Last Close Price
26.9412.00--
PB Ratio
5.342.15--
P/TBV Ratio
5.362.15--
Debt / Equity Ratio
0.240.19-2.08-1.40
Quick Ratio
8.647.143.112.78
Current Ratio
8.847.333.202.86
Return on Equity (ROE)
-89.30%-59.37%--
Return on Assets (ROA)
--18.39%-61.63%-
Return on Capital (ROIC)
-34.64%-22.38%-110.58%-
Earnings Yield
-7.69%-12.95%--
Buyback Yield / Dilution
-462.52%-24.08%68.63%-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q